Zoetis is a holding company. Through its subsidiaries, Co. develops, manufactures and commercializes medicines, vaccines, diagnostic products and services, biodevices, genetic tests and animal health technology. Co.'s product categories include: vaccines, which are biological preparations that help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response; and parasiticides, which are products that prevent or eliminate parasites. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services in biodevices, genetic tests and precision animal health. We show 41 historical shares outstanding datapoints in our ZTS shares outstanding history coverage, used to compute ZTS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ZTS market cap history over the course of time is important for investors
interested in comparing ZTS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ZTS versus a peer is one thing; comparing
ZTS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ZTS can fluctuate over the course of history.
With this page we aim to empower investors researching ZTS by allowing them to research the ZTS market cap history. |
Free ZTS Email Alerts:
Video: The Importance of Market Cap
